Our Experiences with Erlotinib in Second and Third Line Treatment Patients with Advanced Stage Iiib/ Iv Non-Small Cell Lung Cancer. Biomol Biomed [Internet]. 2008 Nov. 20 [cited 2024 May 3];8(4):386-90. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/2905